<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, no specific and sensitive therapeutic regimen is available for the treatment of COVID-19. However, the primary step is isolation to prevent any type of contact that later may cause transmission of the disease. If the patient experiences any mild symptoms, it should be managed at their residence with proper counseling to patients about the critical signs and symptoms. The primary management protocols include the management of cough and fever [
 <xref rid="B89-ijerph-17-05904" ref-type="bibr">89</xref>]. First-line therapy to manage the fever is acetaminophen, while expectorants such as guaifenesin are used for non-productive cough [
 <xref rid="B90-ijerph-17-05904" ref-type="bibr">90</xref>]. Patients with SARS, hypoxemia, respiratory distress or shock should be treated by the administration of instant oxygen therapy. The frequency of oxygen therapy should be 5 L/min to obtain SpO
 <sub>2</sub> of ≥92–95% in pregnant women, and ≥90% in adults and children [
 <xref rid="B91-ijerph-17-05904" ref-type="bibr">91</xref>]. Antiviral therapy is also being tried to manage the infection [
 <xref rid="B92-ijerph-17-05904" ref-type="bibr">92</xref>].
</p>
